| Literature DB >> 33182243 |
Eunhye Jeong1, Jinkyung Park1, Sung Ok Chang1,2.
Abstract
Delirium is highly prevalent and leads to several bad outcomes for older long-term care (LTC) residents. For a more successful translation of delirium knowledge, Clinical Practice Guidelines (CPGs) tailored to LTC should be developed and applied based on the understanding of the barriers to implementation. This study was conducted to develop a CPG for delirium in LTC and to determine the barriers perceived by healthcare professionals related to the implementation of the CPG. We followed a structured, evidence- and theory-based procedure during the development process. After a systematic search, quality appraisal, and selection for eligible up-to-date CPGs for delirium, the recommendations applicable to the LTC were drafted, evaluated, and confirmed by an external group of experts. To evaluate the barriers to guideline uptake from the users' perspectives, semi-structured interviews were conducted which resulted in four major themes: (1) a lack of resources, (2) a tendency to follow mindlines rather than guidelines, (3) passive attitudes, and (4) misunderstanding delirium care in LTC. To minimize adverse prognoses through prompt delirium care, the implementation of a CPG with an approach that comprehensively considers various barriers at the system, practice, healthcare professional, and patients/family levels is necessary.Entities:
Keywords: aged; delirium; guideline; long-term care; nursing home
Year: 2020 PMID: 33182243 PMCID: PMC7664888 DOI: 10.3390/ijerph17218255
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow chart of the search for eligible CPGs. CPG, Clinical practice guideline; G-I-N, Guidelines International Network; KNAL, Korean National Assembly Library.
Characteristics of the included CPGs.
| Title | Developer | Year | Country | Database Source | Target Patient Population | Quality |
|---|---|---|---|---|---|---|
| Inter-professional palliative symptom management guidelines | BCPC | 2017 | Canada | Manual search | adults with any life-limiting illness | 40.0 |
| The assessment and treatment of delirium | CCSMH | 2014 | Canada | G-I-N | older persons | 34.38 |
| Care of dying adults in the last days of life | NICE | 2015 | England | Manual search | adults (≥18) who are dying during their last 2 to 3 days of life | 47.11 |
| Delirium: prevention, diagnosis and management (CG115) | NICE | 2018 | England | G-I-N | adult patients in hospitals or nursing homes | 88.08 b |
| Delirium, dementia, and depression in older adults: assessment and care | RNAO | 2016 | Canada | G-I-N | older adults (>65) | 72.34 b |
| Risk reduction and management of delirium (SIGN CPG 157) | SIGN | 2019 | Scotland | G-I-N/Medline | adults | 83.22 b |
BCPC, British Columbia Center for Palliative Care; CCSMH, Canadian Coalition for Seniors’ Mental Health; EOL, end of life; CPG, clinical practice guideline; G-I-N, Guidelines International Network; NICE, National Institute for Health and Care Excellence; RNAO, Registered Nurses’ Association of Ontario; SIGN, Scottish Intercollegiate Guidelines Network. a Appraisal of Guidelines for Research and Evaluation II (AGREE II) score. b Included for development of CPG (total AGREE II score > 50%).
Recommendations of the developed guidelines.
| PICO Questions | Recommendations | LOE |
|---|---|---|
| 1. What strategy is recommended for preventing delirium in older adults? (1–3) |
(1) Assess older adults for delirium risk factors on initial contact and if there is a change in the person’s condition. If any of these delirium risk factors is present, he or she is considered at high risk. age 65 years or older past or present cognitive impairment, dementia, depression, and/or disorientation severe illness (a clinical condition that is deteriorating or is at risk of deterioration) acute illness and associated abnormal blood values other medical conditions (e.g., infection, fever, dehydration and/or constipation, malnutrition, anemia, hypoxia) sensory deprivation or impairment immobility or limited mobility (e.g., use of physical restraints, prolonged bed rest) sleep deprivation or disturbance poorly controlled pain polypharmacy, use of high-risk medications, or any changes in medications | Ia and V |
|
(2) Develop and implement a tailored, non-pharmacological, multi-component delirium prevention plan for persons at risk of delirium in collaboration with the person, their families (or care partners), and the interprofessional team, even if the person has not been identified as having delirium. providing appropriate lighting and clear signage (a clock and a calendar) talking to the person to re-orientate them introducing cognitively stimulating activities (e.g., reminiscence) facilitating regular visits from family and friends looking for and treating infection, avoiding unnecessary catheterization ensuring adequate fluid intake to prevent dehydration by encouraging the person to drink resolving any reversible cause of the impairment, such as removing impacted ear wax affecting hearing and ensuring hearing/visual aids are in good working order encouraging all people, including those unable to walk, to engage in range-of motion activities and to exercise avoiding nursing or medical procedures during sleeping hours, if possible reducing noise to a minimum during sleep periods looking for non-verbal signs of pain, particularly in those with communication difficulties starting and reviewing appropriate pain management in any person in whom pain is identified or suspected | Ia | |
|
(3) All patients at risk of delirium should have a medication review conducted by an experienced healthcare professional, paying particular attention to medications with increased risk for older adults and polypharmacy. recently started, stopped, or changed (e.g., doses) medications high-risk medications Benzodiazepines (e.g., diazepam, chlordiazepoxide, clonazepam) Opiates (especially pethidine) others (e.g., antipsychotics, antispasmodics, antiepileptics, antihistamines, antihypertensives, corticosteroids, tricyclic antidepressants, digoxin, antiparkinsonian medication) | Ib | |
| 2. What strategy is recommended for early detection of delirium in older adults? (4–8) | (4) Use clinical assessments and validated tools to assess older adults at risk of delirium at least daily (where appropriate) and whenever changes in the person’s cognitive function, perception, physical function, or social behavior are observed or reported. The 4 ‘A’ test (4AT) can be considered for use in identifying older adults with probable delirium. | Ia and V |
|
(5) Assess older adults at risk for recent (within hours or days) changes or fluctuations in behavior by using a validated tool for delirium detection. Be particularly vigilant for behavior indicating hypoactive delirium (marked*). cognitive function: e.g., worsened concentration*, slow responses*, confusion perception: e.g., visual or auditory hallucinations physical function: e.g., reduced mobility*, reduced movement* restlessness, agitation, changes in appetite*, sleep disturbance social behavior: e.g., lack of cooperation with reasonable requests, withdrawal*, or alterations in communication, mood, and/or attitude. | Ia | |
| (6) Identify and differentiate delirium from the signs and symptoms of dementia, and/or depression during assessments, observations, and interactions with older persons, paying close attention to concerns about changes expressed by the person, his/her family/care partners, and the interprofessional team. If there is difficulty distinguishing between the diagnoses of delirium, dementia or delirium superimposed on dementia, treat for delirium first. | V | |
| (7) For older adults whose assessments indicate delirium, notify the qualified clinicians (e.g., attending doctors) or refer older adults to the appropriate clinicians, teams, or services for further assessment and diagnosis. | Ia | |
| (8) When delirium is diagnosed, document clearly in the person’s record and inform the person and his or her family/care partners of the diagnosis. Assess the person’s ability to understand and appreciate information relevant to making decisions and, if the person is incapable of making certain decisions, engage the appropriate substitute decision maker in decision-making and care planning. | V | |
| 3. What strategy is recommended for the intervention of delirium in older adults? (9–17) | (9) For older adults whose assessments indicate delirium, systematically identify the possible underlying cause or combination of causes, noting that multiple causes are common. Referring the person for additional investigation can be considered. | Ia |
| (10) First consider and treat acute, life-threatening causes of delirium, including low oxygen level, low blood pressure, low glucose level, and drug intoxication or withdrawal. Ensure effective communication and reorientation (e.g., explaining where the person is, who they are, and what your role is). | V | |
| (11) Implement tailored, multi-component interventions to actively treat the underlying causes, using non-pharmacological means if possible. | Ia and V | |
| (12) Educate persons who are experiencing delirium and their families/care partners about delirium care and support the person’s ability to make decisions in full or in part. | V | |
|
(13) Although pharmacological treatment is not well supported by evidence, if a person with delirium is distressed or considered a risk to themselves or others and verbal and non-verbal de-escalation techniques are ineffective or inappropriate, consider appropriate use of medications to alleviate the symptoms of delirium. Start at the lowest clinically appropriate dose and titrate cautiously according to symptoms. Haloperidol 0.5–1 mg orally (max 2 mg/24 h) Haloperidol 0.5 mg intramuscularly (IM) (max 2 mg/24 h) (* Haloperidol is contra-indicated in combination with the corrected QT interval (QTc) prolonging drugs, which makes it unlicensed and thus local “off label” policy should be followed.) an atypical antipsychotic at low dose, e.g., Risperidone 0.25 mgs daily, maximum 1 mg in 24 h do not use if there are signs of Parkinsonism or Lewy body dementia. If antipsychotics are contra-indicated (as above), Lorazepam 0.5–1 mg orally (max 2 mg/24 h), Midazolam 2.5 mg IM (max 7.5 mg/24 h). | Ia and V | |
| (14) Use appropriate medications to manage pain. | Ia | |
| (15) Use the principles of least restraint as a last resort when caring for older adults. | V | |
| (16) If delirium does not resolve, re-evaluate for underlying causes. Be aware that older people may have pre-existing cognitive impairment that may have been undetected or has become exacerbated in the context of delirium. Appropriate cognitive and functional assessment should be considered. Timing of this assessment must take into account persistent delirium. | V | |
| (17) Consider referring older adults with delirium to the appropriate clinicians, teams, or services for care. | Ia | |
|
LOE
Evidence obtained from meta-analysis or systematic reviews of randomized controlled trials and/or synthesis of multiple studies primarily of quantitative research. Evidence obtained from at least one randomized controlled trial. Evidence obtained from at least one well-designed controlled study without randomization. Evidence obtained from at least one other type of well-designed quasi-experimental study, without randomization Synthesis of multiple studies primarily of qualitative research. Evidence obtained from well-designed non-experimental observational studies, such as analytical or descriptive studies and/or qualitative studies. Evidence obtained from expert opinion or committee reports and/or clinical experiences of respected authorities. | ||
LOE, Level of evidence; PICO, Patient Intervention Comparison Outcome.
The perceived barriers to implementation of CPG for delirium by healthcare professionals.
| Theme | Sub-Theme | Quotations |
|---|---|---|
| System level | ||
| Lack of resources | Lack of time | “It is difficult because it means that we have to screen (delirium) all 50 people in one day. How much work to do.” P4 |
| Lack of education | “We are very confused between delirium and dementia, but it would be easier if there is such information (education) about how this actually appears in the case and how we should screen and manage it.” P1 | |
| Limited organizational approach | “If it is not compulsory, the guidelines may not be used by those who are not interested.” P6 | |
| Practice level | ||
| Tendency to follow mindlines a rather than guidelines | I am already knowledgeable | “In fact, (we) know all of the patient’s conditions, so there is a question whether this (delirium care) should be done in LTC. All those who take similar medicines and take similar care in a similar state every time, (there is no need for guidelines).” P5 |
| No problems so far | “I have seen little delirium here for many years.” P1 | |
| Healthcare professionals level | ||
| Passive attitude | “Delirium treatment is the responsibility of the doctor, not ours. Non-pharmaceutical interventions are some of the things we can do. We just take a step back and look at the patient.” P4 | |
| Patient/family level | ||
| Misunderstanding about delirium care in LTC | “Caregivers don’t want to actively find the cause (of delirium) or treat it. Some caregivers say, ‘Is it necessary?’ when the patient is in the condition requiring additional treatment or drugs.” P4 | |
CPG, clinical practice guideline; LTC, Long-term care; P, Participants of the interviews. a Mindlines, the usual method or tacit knowledge formed by opinions shared among colleagues.